Baxter Interna…
ProfileJobs (594)

Baxter International

Suggest Edit
    • Healthcaredrug developmentnutritionpharmarehabilitation
    Baxter International develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The Company operates through three segments: BioScience, Medication Delivery, and Renal. It offers peritoneal dialysis and hemodialysis, renal replacement therapies and other organ support therapies, sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, drug reconstitution devices, and parenteral nutrition therapies.
    Revenue(FY, 2017)
    $10.6 B
    Market capitalization(2018-11-09)
    $33.8 B

    Employee Rating

    3.3More
    TypePublic
    HQDeerfield, US
    Founded1931
    Size (employees)47,000 (est)
    Websitebaxter.com
    Baxter International was founded in 1931 and is headquartered in Deerfield, US
    Report incorrect company information

    Viewing summary data as a guest

    Sign up for free to see all data

    Key People/Management at Baxter International

    Jose Almeida

    Jose Almeida

    Chairman, President and Chief Executive Officer
    John Forsyth

    John Forsyth

    Chairman and Chief Executive Officer, Wellmark Blue Cross and Blue Shield
    James Gavin

    James Gavin

    Chief Executive Officer and Chief Medical Officer, Healing Our Village, Inc
    Munib Islam

    Munib Islam

    Partner and Head of Equities Research, Third Point LLC
    Michael Mahoney

    Michael Mahoney

    Chairman, President and Chief Executive Officer, Boston Scientific Corporation
    Cathy Smith

    Cathy Smith

    Executive Vice President and Chief Financial Officer, Target Corporation
    Show more

    Baxter International Office Locations

    Baxter International has offices in Lombard, Houston, Baltimore, Bloomington and in 34 other locations
    Deerfield, US (HQ)
    One Baxter Parkway
    Show all (38)
    Report incorrect company information

    Baxter International Financials and Metrics

    Baxter International Revenue

    Embed Graph
    Baxter International's revenue was reported to be $10.56 b in FY, 2017
    USD

    Revenue (Q2, 2018)

    		2.8b

    Gross profit (Q2, 2018)

    		1.2b

    Gross profit margin (Q2, 2018), %

    		43.6%

    Net income (Q2, 2018)

    		343.0m

    EBIT (Q2, 2018)

    		384.0m

    Market capitalization (9-Nov-2018)

    		33.8b

    Closing stock price (9-Nov-2018)

    		63.5

    Cash (30-Jun-2018)

    		2.9b
    Baxter International's current market capitalization is $33.8 b.
    Annual
    USDFY, 2015FY, 2016FY, 2017

    Revenue

    		10.0b10.2b10.6b

    Revenue growth, %

    		(40%)2%

    Cost of goods sold

    		5.8b6.1b6.1b

    Gross profit

    		4.1b4.1b4.5b
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

    Revenue

    		3.8b4.0b4.3b4.2b3.8b3.9b2.5b2.4b2.6b2.6b2.5b2.6b2.7b2.8b

    Cost of goods sold

    		1.8b2.0b2.2b2.1b2.0b2.0b1.5b1.4b1.6b1.5b1.4b1.5b1.6b1.6b

    Gross profit

    		1.9b2.0b2.0b2.1b1.8b1.9b1.0b965.0m972.0m1.1b1.0b1.1b1.1b1.2b

    Gross profit Margin, %

    		52%50%48%49%48%49%42%41%38%42%42%43%42%44%
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Cash

    		2.7b2.9b2.2b2.8b3.4b

    Inventories

    		3.5b3.6b1.6b1.4b1.5b

    Current Assets

    		10.0b10.4b11.8b6.6b7.3b

    PP&E

    		7.8b8.7b4.4b4.3b4.6b
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

    Cash

    		2.4b2.0b1.9b2.1b2.5b6.7b2.0b2.2b2.6b2.6b2.9b3.8b2.9b2.9b

    Inventories

    		3.6b3.7b3.8b3.7b3.5b3.8b1.7b1.7b1.6b1.6b1.5b1.5b1.6b1.6b

    Current Assets

    		9.6b9.4b9.5b9.6b9.7b14.5b11.1b8.0b6.8b6.6b6.6b7.7b7.0b6.9b

    PP&E

    		7.5b8.0b8.2b8.4b8.5b9.0b4.3b4.4b4.3b4.3b4.3b4.3b4.6b4.5b
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Net Income

    		2.0b2.5b968.0m5.0b717.0m

    Depreciation and Amortization

    		761.0m

    Inventories

    		(311.0m)(439.0m)1.6b80.0m76.0m

    Accounts Payable

    		84.0m
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

    Net Income

    		544.0m556.0m1.1b468.0m430.0m762.0m763.0m3.4b4.6b4.7b272.0m537.0m389.0m732.0m

    Depreciation and Amortization

    		236.0m489.0m497.0m593.0m189.0m395.0m599.0m194.0m378.0m192.0m387.0m

    Inventories

    		(233.0m)(360.0m)(439.0m)(205.0m)(26.0m)(25.0m)(11.0m)(29.0m)(38.0m)(56.0m)(134.0m)

    Accounts Payable

    		(236.0m)(222.0m)(34.0m)14.0m(343.0m)(326.0m)(262.0m)(112.0m)(103.0m)(109.0m)
    show all
    USDY, 2018

    Financial Leverage

    		1.9 x
    Show all financial metrics
    Report incorrect company information

    Competitors

    Fresenius Medical Care
    Healthcare - Public
    Medtronic
    Healthcare - Public
    Generex Biotechnology
    Healthcare - Public
    Vitality Biopharma
    Healthcare - Public
    Compare competitors

    Baxter International Online and Social Media Presence

    Embed Graph
    Report incorrect company information

    Baxter International News and Updates

    October 22, 2018

    Bio-Mems Devices 2018 Global Market Key Players – Abbott Laboratories, Boston Scientific, Perkin Elmer, Medtronic, Baxter International – Analysis and Forecast to 2023

    WiseGuyRerports.com Presents “Global Bio-Mems Devices Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023” New Document to its Studies Database. Posted via Industry Today. Follow us on Twitter @IndustryToday
    October 11, 2018

    Future detailed in new report by Kidney Dialysis Equipment Market 2018: by Asahi Kasei Medical, Baxter International, Nikkiso Group.

    Global Kidney Dialysis Equipment Market is expected to grow at a Compound Annual Growth Rate (CAGR) of +6.8%. The base year considered for the study is 2018 and the forecast period considered is 2018 To 2025. Posted via Industry Today. Follow us on Twitter @IndustryToday
    August 31, 2018

    Global Nephrology and Urology Devices Market Analysis & Forecasts, 2018-2024: Key Players are Baxter International, Fresenius Medical Care, Boston Scientific & C.R. Bard

    DUBLIN, Aug 31, 2018 /PRNewswire/ -- The "Nephrology and Urology Devices Market Analysis Report By Type (Dialysis, Benign Prostatic Hyperplasia, Endoscopy, Urinary Stone, Urinary Incontinence & Pelvic Organ Prolapse), And Segment Forecasts, 2018 - 2024" report has been added to...
    August 21, 2018

    Tissue Sealants Global Market 2018: Key Players – 3M Company, Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., C. R. Bard, Inc.

    Tissue Sealants -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021 Posted via Industry Today. Follow us on Twitter @IndustryToday
    August 21, 2018

    Stem Cell Research in Cardiology Global Market 2018: Key Players – Athersys, Inc., Axordia Ltd, Baxter International, U.S. Stem Cell, Inc, Vericel Corporation

    Stem Cell Research in Cardiology -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021 Posted via Industry Today. Follow us on Twitter @IndustryToday
    August 21, 2018

    Stem Cell Research in Cardiology Global Market 2018: Key Players – Athersys, Inc., Axordia Ltd, Baxter International, U.S. Stem Cell, Inc, Vericel Corporation

    Stem Cell Research in Cardiology -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021 Posted via Industry Today. Follow us on Twitter @IndustryToday
    Show more
    Report incorrect company information

    Baxter International Company Life and Culture

    Report incorrect company information
    Download PDF

     Baxter International Frequently Asked Questions

    • When was Baxter International founded?

      Baxter International was founded in 1931.

    • Who are Baxter International key executives?

      Baxter International's key executives are Jose Almeida, John Forsyth and James Gavin.

    • How many employees does Baxter International have?

      Baxter International has 47,000 employees.

    • What is Baxter International revenue?

      Latest Baxter International annual revenue is $10.6 b.

    • What is Baxter International revenue per employee?

      Latest Baxter International revenue per employee is $224.7 k.

    • Who are Baxter International competitors?

      Competitors of Baxter International include Fresenius Medical Care, Medtronic and Generex Biotechnology.

    • Where is Baxter International headquarters?

      Baxter International headquarters is located at One Baxter Parkway, Deerfield.

    • Where are Baxter International offices?

      Baxter International has offices in Lombard, Houston, Baltimore, Bloomington and in 34 other locations.

    • How many offices does Baxter International have?

      Baxter International has 38 offices.